A new treatment possibility has been confirmed for ischemic cardiovascular disease, which does not have a suitable treatment ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia (K.R.P., J.T.M.T., V.A.N., L.G.S., E.L.S., P.J.P ...

Furthermore, the subset of patients with digital vascular lesions and high severity score displayed low EPC counts ... of these cell in patients with SSc (n = 5), healthy controls (n = 5) and human ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that ...

Atherosclerosis (AS) is a chronic inflammatory disease characterized by the buildup of lipids and immune cells in arterial ...

The entire 36-week data for the remaining subjects in the trial is anticipated in the second quarter of this year.

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...

Summit Therapeutics (NASDAQ: SMMT) is one of those stocks that have been quite explosive: The share price of the ...

Cesarean section, a surgical procedure for delivering a baby through an incision made in the mother’s abdomen, is generally ...